Clinical Trial Update: Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM) [Phase 1]

View source ↗

Summary

This clinical trial update notes a Phase 1 study evaluating pembrolizumab in combination with chemotherapy and image-guided surgery for malignant pleural mesoth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Mesotheliomas Pleural | Phase 1 | Status: RECRUITING